BioTelemetry (BEAT) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts BEAT Hot Sheet
Join SI Premium – FREE
BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.32, $0.08 better than the analyst estimate of $0.24. Revenue for the quarter came in at $91.7 million versus the consensus estimate of $88.3 million.
For earnings history and earnings-related data on BioTelemetry (BEAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Genuine Parts (GPC) Tops Q1 EPS by 5c, Offers Guidance
- Endexx Corporation (EDXC) Reports Q1 Loss of $0.01
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
